<DOC>
	<DOC>NCT00116623</DOC>
	<brief_summary>The purpose of this study is to investigate the efficacy of Indomethacin compared to Magnesium Sulfate (MgSO4) in reducing neonatal morbidity through a prospective double blind randomized clinical trial. The specific aim of the project is to test the hypothesis that Indomethacin, compared to MgSO4, will decrease the proportion of neonates diagnosed with major complications or death.</brief_summary>
	<brief_title>Magnesium Sulfate Versus Indomethacin for Preterm Labor</brief_title>
	<detailed_description />
	<mesh_term>Obstetric Labor, Premature</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<criteria>Initial episode of preterm labor for enrollment The diagnosis of preterm labor Gestational age between 24 and 32 weeks Singleton or twin gestation The ability to understand the requirements of the study Cervical dilation &gt;5 cms Suspected chorioamnionitis Fetal distress Vaginal bleeding Severe preeclampsia History of gastrointestinal bleeding Abnormal renal function Suspicion of fetal malformation by ultrasound Known allergy to, or intolerance of, Magnesium sulfate and/or Indomethacin Documented rupture of amniotic membranes Multiple gestations of triplets or more.</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>